Evidence map›Paper›PMID 25762783›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

DAP12 expression in lung macrophages mediates ischemia/reperfusion injury by promoting neutrophil extravasation.

Jessica H Spahn, Wenjun Li, Alejandro C Bribriesco, Jie Liu, Hua Shen, Aida Ibricevic, Jie-Hong Pan, Bernd H Zinselmeyer, Steven L Brody, Daniel R Goldstein and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 64 citations in OpenAlex.

  1. Activation of donor-derived eosinophils during static storage contributes to primary graft dysfunction after lung transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Nanoparticle targeting of neutrophil glycolysis prevents lung ischemia-reperfusion injury.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Resolvin D1 prevents injurious neutrophil swarming in transplanted lungs.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Article
  16. Necroptosis triggers spatially restricted neutrophil-mediated vascular damage during lung ischemia reperfusion injury.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jessica H SpahnDepartment of Surgery, Washington University, St. Louis, MO 63110;
Wenjun LiDepartment of Surgery, Washington University, St. Louis, MO 63110;
Alejandro C BribriescoDepartment of Surgery, Washington University, St. Louis, MO 63110;
Jie LiuDepartment of Surgery, Washington University, St. Louis, MO 63110;
Hua ShenDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06510;
Aida IbricevicDepartment of Medicine, Washington University, St. Louis, MO 63110; and.
Jie-Hong PanDepartment of Medicine, Washington University, St. Louis, MO 63110; and.
Bernd H ZinselmeyerDepartment of Pathology & Immunology, Washington University, St. Louis, MO 63110.
Steven L BrodyDepartment of Medicine, Washington University, St. Louis, MO 63110; and.
Daniel R GoldsteinDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06510;
Alexander S KrupnickDepartment of Surgery, Washington University, St. Louis, MO 63110;
Andrew E GelmanDepartment of Surgery, Washington University, St. Louis, MO 63110; Department of Pathology & Immunology, Washington University, St. Louis, MO 63110.
Mark J MillerDepartment of Medicine, Washington University, St. Louis, MO 63110; and.
Daniel KreiselDepartment of Surgery, Washington University, St. Louis, MO 63110; Department of Pathology & Immunology, Washington University, St. Louis, MO 63110 kreiseld@wudosis.wustl.edu.
Washington University in St. Louis · USYale University · US

Funding

Mechanisms to augment primary immunity in agingR01AG028082 · NIA · YALE UNIVERSITY · PI DENG, JANE C · 2007 to 2023
$6.9M
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTIONR01HL094601 · NHLBI · WASHINGTON UNIVERSITY · PI Andrew Eric Gelman, Daniel Kreisel · 2009 to 2026
$6.9M
BASIC SCIENCE RESEARCH TRAINING: CARDIOPULMONARY SURGERYT32HL007776 · NHLBI · WASHINGTON UNIVERSITY · PI DAMIANO, RALPH J · 1994 to 2020
$4.6M
Epithelial Responses to Bacterial InvasionR01AI077600 · NIAID · WASHINGTON UNIVERSITY · PI MILLER, MARK JAMES · 2009 to 2021
$3.8M
GRANULOPOIESIS REGULATION IN LUNG GRAFT ISCHEMIA-REPERFUSION INJURYR01HL113436 · NHLBI · WASHINGTON UNIVERSITY · PI GELMAN, ANDREW ERIC · 2013 to 2016
$1.5M
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCER01HL113931 · NHLBI · WASHINGTON UNIVERSITY · PI KREISEL, DANIEL, KRUPNICK, ALEXANDER S. · 2012 to 2015
$1.5M
NHLBI NIH HHS R01 HL094601NHLBI NIH HHS R01 HL113436NHLBI NIH HHS R01 HL113931NHLBI NIH HHS T32 HL007776NIAID NIH HHS R01 AI077600NIA NIH HHS R01 AG028082
6 · The paper itself

Abstract

Neutrophils are critical mediators of innate immune responses and contribute to tissue injury. However, immune pathways that regulate neutrophil recruitment to injured tissues during noninfectious inflammation remain poorly understood. DAP12 is a cell membrane-associated protein that is expressed in myeloid cells and can either augment or dampen innate inflammatory responses during infections. To elucidate the role of DAP12 in pulmonary ischemia/reperfusion injury (IRI), we took advantage of a clinically relevant mouse model of transplant-mediated lung IRI. This technique allowed us to dissect the importance of DAP12 in tissue-resident cells and those that infiltrate injured tissue from the periphery during noninfectious inflammation. Macrophages in both mouse and human lungs that have been subjected to cold ischemic storage express DAP12. We found that donor, but not recipient, deficiency in DAP12 protected against pulmonary IRI. Analysis of the immune response showed that DAP12 promotes the survival of tissue-resident alveolar macrophages and contributes to local production of neutrophil chemoattractants. Intravital imaging demonstrated a transendothelial migration defect into DAP12-deficient lungs, which can be rescued by local administration of the neutrophil chemokine CXCL2. We have uncovered a previously unrecognized role for DAP12 expression in tissue-resident alveolar macrophages in mediating acute noninfectious tissue injury through regulation of neutrophil trafficking.

Indexed as

Lung TransplantationAdaptor Proteins, Signal TransducingAnimalsChemokine CXCL2Gene Expression RegulationHumansLungMacrophages, AlveolarMiceMice, KnockoutNeutrophil InfiltrationNeutrophilsPrimary Graft DysfunctionAdaptor Proteins, Signal TransducingChemokine CXCL2Cxcl2 protein, mouseTyrobp protein, mouse

Identifiers

PMID25762783
PMCPMC4401083
OpenAlexW2133398087

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.